文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Hidradenitis suppurativa: a new therapeutic approach for an old disease.

作者信息

Billewicz Marta, Wojtania Joanna, Woźniacka Anna

机构信息

Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland.

出版信息

Postepy Dermatol Alergol. 2024 Aug;41(4):350-356. doi: 10.5114/ada.2024.142185. Epub 2024 Aug 12.


DOI:10.5114/ada.2024.142185
PMID:39290899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11404097/
Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory disease characterised by recurrent painful nodules, abscesses, fistulas and scarring. The primary distinguishing factor in the complex, yet still not fully understood, pathogenesis is an inflammation occurring within the hair follicle, followed by an immune response leading to further development of the skin lesions seen in HS. The treatment of patients with HS is very difficult due to the complexity of the lesions and the frequent tendency to recurrence, which also has a negative impact on the psychological state of patients and directly translates into a reduced quality of life. This review article addresses the pathogenesis, clinical presentation of HS and, in particular, explores the new therapeutic options available.

摘要

相似文献

[1]
Hidradenitis suppurativa: a new therapeutic approach for an old disease.

Postepy Dermatol Alergol. 2024-8

[2]
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.

Acta Dermatovenerol Croat. 2021-7

[3]
New perspectives on the treatment of hidradenitis suppurativa.

Ther Adv Chronic Dis. 2021-11-23

[4]
[Hidradenitis suppurativa/acne inversa: An update].

Hautarzt. 2015-6

[5]
S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.

J Dtsch Dermatol Ges. 2024-6

[6]
Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.

Rev Endocr Metab Disord. 2016-9

[7]
Hidradenitis suppurativa: a review of current treatment options.

Int J Dermatol. 2022-9

[8]
Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa-Possibilities and Limitations.

Int J Mol Sci. 2022-8-26

[9]
Rethinking Hidradenitis Suppurativa Management: Insights into Bacterial Interactions and Treatment Evolution.

Antibiotics (Basel). 2024-3-17

[10]
[Acne inversa].

Hautarzt. 2010-1

本文引用的文献

[1]
Successful treatment of Hidradenitis Suppurativa with tofacitinib: two cases and a review of the literature.

Oxf Med Case Reports. 2023-3-25

[2]
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.

Lancet. 2023-3-4

[3]
Stress signalling and STAT1 activation characterize the keratinocytic gene expression pattern in Hidradenitis suppurativa.

J Eur Acad Dermatol Venereol. 2022-12

[4]
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on 'Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?'.

Clin Exp Dermatol. 2022-10

[5]
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.

JAMA Dermatol. 2021-11-1

[6]
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.

J Am Acad Dermatol. 2021-8

[7]
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside.

Front Immunol. 2020

[8]
Efficacy of high-dose intralesional triamcinolone for hidradenitis suppurativa.

Int J Dermatol. 2021-2

[9]
Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance.

Br J Dermatol. 2020-12

[10]
Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases).

J Eur Acad Dermatol Venereol. 2020-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索